Data search


search
Exact
Search

Results for MligTC455_38890

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_38890 2008 41.84 Mlig455_023830, Mlig455_038904, Mlig455_063874, Mlig455_063891

Neo: -

Age: Down-Up-Up

Region-enriched R3: 2.082/0.00072

MEF2A, MEF2B

Mlig455_023830 {REF} {Length: 1616} {Pfam: SRF-type transcription factor (DNA-binding and dimerisation domain) [PF00319.20, score=88.1]} {Human: ENSG00000213999, MEF2B, myocyte enhancer factor 2B, [RH, Score=174, Expect=2e-52]; ENSG00000064489, BORCS8-MEF2B, BORCS8-MEF2B readthrough, [RH, Score=173, Expect=4e-52]} {Mouse: ENSMUSG00000005583, Mef2c, myocyte enhancer factor 2C, [RH, Score=177, Expect=2e-55]} {Dmel: FBgn0011656, Mef2, Myocyte enhancer factor 2, [Score=161, Expect=1e-46]} {Celegans: WBGene00003182, mef-2, Related to vertebrate MEF2 transcription factor, [RH, Score=179, Expect=3e-55]} {Smed: dd_Smed_v6_5317_0_1, dd_Smed_v6_5317_0_1, [RH, Score=161, Expect=1e-46]} {RNA1509_9417} {RNA1310_18822} {RNA815_5423.1}

Mlig455_038904 {REF} {Length: 5234} {Human: ENSG00000068305, MEF2A, myocyte enhancer factor 2A, [Score=55.8, Expect=7e-09]; ENSG00000081189, MEF2C, myocyte enhancer factor 2C, [Score=53.5, Expect=3e-08]} {Mouse: ENSMUSG00000005583, Mef2c, myocyte enhancer factor 2C, [Score=56.2, Expect=4e-09]; ENSMUSG00000030557, Mef2a, myocyte enhancer factor 2A, [Score=55.8, Expect=5e-09]} {Celegans: WBGene00003182, mef-2, Related to vertebrate MEF2 transcription factor, [Score=56.2, Expect=1e-09]} {RNA1509_50515, RNA1509_9417} {RNA1310_18822, RNA1509_50515} {RNA1509_50515, RNA815_5423.1}

Mlig455_063874 {REF} {Length: 1834} {Pfam: SRF-type transcription factor (DNA-binding and dimerisation domain) [PF00319.20, score=88.1]} {Human: ENSG00000068305, MEF2A, myocyte enhancer factor 2A, [RH, Score=181, Expect=5e-54]; ENSG00000213999, MEF2B, myocyte enhancer factor 2B, [RH, Score=176, Expect=4e-53]; ENSG00000064489, BORCS8-MEF2B, BORCS8-MEF2B readthrough, [RH, Score=174, Expect=1e-52]} {Mouse: ENSMUSG00000005583, Mef2c, myocyte enhancer factor 2C, [RH, Score=181, Expect=3e-54]; ENSMUSG00000030557, Mef2a, myocyte enhancer factor 2A, [RH, Score=181, Expect=3e-54]} {Dmel: FBgn0011656, Mef2, Myocyte enhancer factor 2, [Score=162, Expect=5e-47]} {Celegans: WBGene00003182, mef-2, Related to vertebrate MEF2 transcription factor, [RH, Score=180, Expect=2e-55]} {Smed: dd_Smed_v6_5317_0_1, dd_Smed_v6_5317_0_1, [Score=157, Expect=3e-45]} {RNA1509_30846} {RNA1310_18822, RNA1509_30846} {RNA1509_30846, RNA815_5423.1}

Mlig455_063891 {REF} {Length: 1818} {Pfam: SRF-type transcription factor (DNA-binding and dimerisation domain) [PF00319.20, score=86.6]} {Human: ENSG00000213999, MEF2B, myocyte enhancer factor 2B, [RH, Score=172, Expect=1e-51]; ENSG00000064489, BORCS8-MEF2B, BORCS8-MEF2B readthrough, [RH, Score=171, Expect=2e-51]} {Mouse: ENSMUSG00000030557, Mef2a, myocyte enhancer factor 2A, [Score=177, Expect=6e-53]; ENSMUSG00000005583, Mef2c, myocyte enhancer factor 2C, [Score=177, Expect=7e-53]; ENSMUSG00000001419, Mef2d, myocyte enhancer factor 2D, [Score=170, Expect=5e-50]} {Dmel: FBgn0011656, Mef2, Myocyte enhancer factor 2, [Score=158, Expect=1e-45]} {Celegans: WBGene00003182, mef-2, Related to vertebrate MEF2 transcription factor, [Score=177, Expect=3e-54]} {Smed: dd_Smed_v6_5317_0_1, dd_Smed_v6_5317_0_1, [Score=154, Expect=5e-44]} {RNA1509_30846, RNA1509_9417} {RNA1310_18822, RNA1509_9417} {RNA1509_9417, RNA815_5423.1}

Cumulative graph for MligTC455_38890

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 -3.952 5.544 0.00226 0.15261
RegionR2 1.173 5.544 0.05192 0.27245
RegionR3 2.082 5.544 0.00001 0.00072
RegionR4 1.142 5.544 0.03437 0.14953
RegionR5 1.067 5.544 0.02636 0.11813
RegionR6 0.648 5.544 0.20817 0.78466
RegionR7 -0.139 5.544 0.81278 1.00000
RegionR8 -2.022 5.544 0.00975 0.18621

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 2.594 5.544 0.09916 0.81498
RegenerationR2 -0.763 5.544 0.19282 0.63696
RegenerationR3 -0.542 5.544 0.36188 0.77813
RegenerationR4 0.319 5.544 0.59499 0.91121
RegenerationR5 0.486 5.544 0.40903 0.80472
RegenerationR6 -0.057 5.544 0.92485 1.00000
RegenerationBL 0.179 5.544 0.76502 1.00000
RegenerationTP 2.131 5.544 0.00067 0.03784


Genes with expression patterns similar to MligTC455_38890

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_38890 2008 41.84 Mlig455_023830, Mlig455_038904, Mlig455_063874, Mlig455_063891

Neo: -

Age: Down-Up-Up

Region-enriched R3: 2.082/0.00072

MEF2A, MEF2B 6 1.000 1.000 1.000 1.000 1.000 1.000

Mlig455_023830 {REF} {Length: 1616} {Pfam: SRF-type transcription factor (DNA-binding and dimerisation domain) [PF00319.20, score=88.1]} {Human: ENSG00000213999, MEF2B, myocyte enhancer factor 2B, [RH, Score=174, Expect=2e-52]; ENSG00000064489, BORCS8-MEF2B, BORCS8-MEF2B readthrough, [RH, Score=173, Expect=4e-52]} {Mouse: ENSMUSG00000005583, Mef2c, myocyte enhancer factor 2C, [RH, Score=177, Expect=2e-55]} {Dmel: FBgn0011656, Mef2, Myocyte enhancer factor 2, [Score=161, Expect=1e-46]} {Celegans: WBGene00003182, mef-2, Related to vertebrate MEF2 transcription factor, [RH, Score=179, Expect=3e-55]} {Smed: dd_Smed_v6_5317_0_1, dd_Smed_v6_5317_0_1, [RH, Score=161, Expect=1e-46]} {RNA1509_9417} {RNA1310_18822} {RNA815_5423.1}

Mlig455_038904 {REF} {Length: 5234} {Human: ENSG00000068305, MEF2A, myocyte enhancer factor 2A, [Score=55.8, Expect=7e-09]; ENSG00000081189, MEF2C, myocyte enhancer factor 2C, [Score=53.5, Expect=3e-08]} {Mouse: ENSMUSG00000005583, Mef2c, myocyte enhancer factor 2C, [Score=56.2, Expect=4e-09]; ENSMUSG00000030557, Mef2a, myocyte enhancer factor 2A, [Score=55.8, Expect=5e-09]} {Celegans: WBGene00003182, mef-2, Related to vertebrate MEF2 transcription factor, [Score=56.2, Expect=1e-09]} {RNA1509_50515, RNA1509_9417} {RNA1310_18822, RNA1509_50515} {RNA1509_50515, RNA815_5423.1}

Mlig455_063874 {REF} {Length: 1834} {Pfam: SRF-type transcription factor (DNA-binding and dimerisation domain) [PF00319.20, score=88.1]} {Human: ENSG00000068305, MEF2A, myocyte enhancer factor 2A, [RH, Score=181, Expect=5e-54]; ENSG00000213999, MEF2B, myocyte enhancer factor 2B, [RH, Score=176, Expect=4e-53]; ENSG00000064489, BORCS8-MEF2B, BORCS8-MEF2B readthrough, [RH, Score=174, Expect=1e-52]} {Mouse: ENSMUSG00000005583, Mef2c, myocyte enhancer factor 2C, [RH, Score=181, Expect=3e-54]; ENSMUSG00000030557, Mef2a, myocyte enhancer factor 2A, [RH, Score=181, Expect=3e-54]} {Dmel: FBgn0011656, Mef2, Myocyte enhancer factor 2, [Score=162, Expect=5e-47]} {Celegans: WBGene00003182, mef-2, Related to vertebrate MEF2 transcription factor, [RH, Score=180, Expect=2e-55]} {Smed: dd_Smed_v6_5317_0_1, dd_Smed_v6_5317_0_1, [Score=157, Expect=3e-45]} {RNA1509_30846} {RNA1310_18822, RNA1509_30846} {RNA1509_30846, RNA815_5423.1}

Mlig455_063891 {REF} {Length: 1818} {Pfam: SRF-type transcription factor (DNA-binding and dimerisation domain) [PF00319.20, score=86.6]} {Human: ENSG00000213999, MEF2B, myocyte enhancer factor 2B, [RH, Score=172, Expect=1e-51]; ENSG00000064489, BORCS8-MEF2B, BORCS8-MEF2B readthrough, [RH, Score=171, Expect=2e-51]} {Mouse: ENSMUSG00000030557, Mef2a, myocyte enhancer factor 2A, [Score=177, Expect=6e-53]; ENSMUSG00000005583, Mef2c, myocyte enhancer factor 2C, [Score=177, Expect=7e-53]; ENSMUSG00000001419, Mef2d, myocyte enhancer factor 2D, [Score=170, Expect=5e-50]} {Dmel: FBgn0011656, Mef2, Myocyte enhancer factor 2, [Score=158, Expect=1e-45]} {Celegans: WBGene00003182, mef-2, Related to vertebrate MEF2 transcription factor, [Score=177, Expect=3e-54]} {Smed: dd_Smed_v6_5317_0_1, dd_Smed_v6_5317_0_1, [Score=154, Expect=5e-44]} {RNA1509_30846, RNA1509_9417} {RNA1310_18822, RNA1509_9417} {RNA1509_9417, RNA815_5423.1}
2. MligTC455_42851 713 14.85 Mlig455_013843

Neo: -

Age: logFC(26M/2M)=-0.350

Region-enriched R3: 1.623/0.00079

TTPAL 1.744 - - - 0.794 - 0.950 Mlig455_013843 {REF} {Length: 3578} {Pfam: CRAL/TRIO domain [PF00650.22, score=53.4]} {Human: ENSG00000124120, TTPAL, alpha tocopherol transfer protein like, [Score=99.0, Expect=4e-23]} {Mouse: ENSMUSG00000017679, Ttpal, tocopherol (alpha) transfer protein-like, [Score=94.7, Expect=1e-21]} {Dmel: FBgn0050339, CG30339, [Score=94.0, Expect=7e-22]} {Smed: dd_Smed_v6_2760_0_1, dd_Smed_v6_2760_0_1, [Score=186, Expect=1e-56]} {RNA1509_23338, RNA1509_25583, RNA1509_34592} {RNA1310_5837, RNA1509_23338, RNA1509_25583, RNA1509_34592} {RNA1509_23338, RNA1509_25583, RNA1509_34592, RNA815_7164}
3. MligTC455_52038 1730 36.03 Mlig455_015106

Neo: -

Age: -

Region-enriched R3: 1.279/0.00028

ACOX1 0.964 - - - - - 0.964 Mlig455_015106 {REF} {Length: 2669} {TRANSSPLICED} {Pfam: Acyl-CoA oxidase [PF01756.21, score=146.2]; Acyl-coenzyme A oxidase N-terminal [PF14749.8, score=121.0]; Acyl-CoA dehydrogenase, middle domain [PF02770.21, score=48.6]; Acyl-CoA dehydrogenase, C-terminal domain [PF00441.26, score=23.4]} {Human: ENSG00000161533, ACOX1, acyl-CoA oxidase 1, [RH, Score=600, Expect=0.0]} {Mouse: ENSMUSG00000020777, Acox1, acyl-Coenzyme A oxidase 1, palmitoyl, [RH, Score=605, Expect=0.0]} {Dmel: FBgn0027572, CG5009, [RH, Score=484, Expect=3e-163]} {Celegans: WBGene00010336, acox-1.6, Acyl-coenzyme A oxidase, [RH, Score=505, Expect=2e-171]} {Smed: dd_Smed_v6_3804_0_1, dd_Smed_v6_3804_0_1, [Score=253, Expect=1e-74]} {RNA1509_2548} {RNA1310_6629} {RNA815_1719.1}
4. MligTC455_16520 1751 36.48 Mlig455_052750

Neo: -

Age: -

0.962 - - - 0.962 - - Mlig455_052750 {REF} {Length: 2878} {Pfam: WH2 motif [PF02205.22, score=34.4]} {Smed: dd_Smed_v6_9660_0_1, dd_Smed_v6_9660_0_1, [RH, Score=48.5, Expect=1e-06]} {RNA1509_16839} {RNA1310_3084.1} {RNA815_2841.1}
5. MligTC455_15742 2363 49.23 Mlig455_039986

Neo: -

Age: logFC(26M/2M)=0.419

ACSF3 0.959 - - - - - 0.959 Mlig455_039986 {REF} {Length: 1745} {TRANSSPLICED} {Pfam: AMP-binding enzyme [PF00501.30, score=221.6]; AMP-binding enzyme C-terminal domain [PF13193.8, score=68.1]} {Human: ENSG00000176715, ACSF3, acyl-CoA synthetase family member 3, [RH, Score=337, Expect=2e-108]} {Mouse: ENSMUSG00000015016, Acsf3, acyl-CoA synthetase family member 3, [RH, Score=338, Expect=2e-109]} {Dmel: FBgn0029945, CG18155, [RH, Score=182, Expect=3e-50]} {Celegans: WBGene00016849, acs-21, Fatty Acid CoA Synthetase family, [RH, Score=220, Expect=4e-65]} {Smed: dd_Smed_v6_10135_0_1, dd_Smed_v6_10135_0_1, [Score=121, Expect=3e-29]} {RNA1509_58234} {RNA1310_24827, RNA1509_58234} {RNA1509_58234, RNA815_5254}
6. MligTC455_28007 1409 29.35 Mlig455_001316

Neo: -

Age: -

SQOR 0.958 - - - - - 0.958 Mlig455_001316 {REF} {Length: 1967} {Pfam: Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=70.5]; FAD-NAD(P)-binding [PF13454.8, score=20.3]} {Human: ENSG00000137767, SQOR, sulfide quinone oxidoreductase, [RH, Score=416, Expect=1e-142]} {Mouse: ENSMUSG00000005803, Sqor, sulfide quinone oxidoreductase, [RH, Score=397, Expect=1e-135]} {Dmel: FBgn0035515, CG14997, [RH, Score=387, Expect=1e-131]} {Celegans: WBGene00008538, sqrd-1, Sulfide Quinone oxidoReDuctase, [RH, Score=350, Expect=1e-117]} {Smed: dd_Smed_v6_4215_0_1, dd_Smed_v6_4215_0_1, [RH, Score=440, Expect=6e-153]} {RNA1509_26256} {RNA1310_11214} {RNA815_2609}
7. MligTC455_51564 815 16.99 Mlig455_004028

Neo: -

Age: -

Region-enriched R5: 1.089/0.00019

AUH 0.955 - - - - - 0.955 Mlig455_004028 {REF} {Length: 1061} {TRANSSPLICED} {Pfam: Enoyl-CoA hydratase/isomerase [PF00378.22, score=199.5]; Enoyl-CoA hydratase/isomerase [PF16113.7, score=114.5]} {Human: ENSG00000148090, AUH, AU RNA binding methylglutaconyl-CoA hydratase, [RH, Score=260, Expect=3e-85]; ENSG00000121310, ECHDC2, enoyl-CoA hydratase domain containing 2, [RH, Score=255, Expect=7e-84]} {Mouse: ENSMUSG00000028601, Echdc2, enoyl Coenzyme A hydratase domain containing 2, [RH, Score=259, Expect=1e-85]; ENSMUSG00000021460, Auh, AU RNA binding protein/enoyl-coenzyme A hydratase, [RH, Score=258, Expect=7e-85]} {Dmel: FBgn0033761, CG8778, [RH, Score=275, Expect=8e-92]} {Celegans: WBGene00001154, ech-5, Enoyl-CoA Hydratase, [RH, Score=232, Expect=3e-75]} {Smed: dd_Smed_v6_3553_0_1, dd_Smed_v6_3553_0_1, [RH, Score=291, Expect=2e-98]} {RNA1509_30724} {RNA1310_10747.1} {RNA815_15836}
8. MligTC455_52557 1418 29.54 Mlig455_024343

Neo: -

Age: Down-Up-Up

Regeneration-downregulated BL: -1.494

Regeneration-depleted BL: -1.494

ANXA13 0.955 - - - - - 0.955 Mlig455_024343 {REF} {Length: 1578} {Pfam: Annexin [PF00191.22, score=277.2]} {Human: ENSG00000104537, ANXA13, annexin A13, [Score=263, Expect=3e-86]; ENSG00000196975, ANXA4, annexin A4, [Score=255, Expect=2e-83]} {Mouse: ENSMUSG00000029994, Anxa4, annexin A4, [Score=248, Expect=7e-81]; ENSMUSG00000021866, Anxa11, annexin A11, [Score=244, Expect=8e-77]; ENSMUSG00000021950, Anxa8, annexin A8, [Score=241, Expect=6e-78]; ENSMUSG00000021814, Anxa7, annexin A7, [Score=236, Expect=3e-74]} {Dmel: FBgn0030749, AnxB11, Annexin B11, [Score=246, Expect=3e-80]} {Celegans: WBGene00003589, nex-2, Annexin, [Score=220, Expect=1e-68]} {Smed: dd_Smed_v6_5798_0_1, dd_Smed_v6_5798_0_1, [Score=272, Expect=6e-86]} {RNA1509_21408} {RNA1310_4220.1} {RNA815_1223.1}
9. MligTC455_32761 994 20.72 Mlig455_031205

Neo: -

Age: Down-Down-Up

TTPAL 0.952 - - - - - 0.952 Mlig455_031205 {REF} {Length: 1688} {Pfam: CRAL/TRIO domain [PF00650.22, score=52.1]} {Human: ENSG00000124120, TTPAL, alpha tocopherol transfer protein like, [Score=105, Expect=2e-25]; ENSG00000177182, CLVS1, clavesin 1, [Score=104, Expect=7e-25]; ENSG00000146352, CLVS2, clavesin 2, [Score=103, Expect=1e-24]} {Mouse: ENSMUSG00000017679, Ttpal, tocopherol (alpha) transfer protein-like, [Score=107, Expect=5e-26]; ENSMUSG00000019785, Clvs2, clavesin 2, [Score=103, Expect=4e-25]; ENSMUSG00000041216, Clvs1, clavesin 1, [Score=103, Expect=1e-24]} {Dmel: FBgn0036289, CG10657, [Score=114, Expect=5e-29]} {Smed: dd_Smed_v6_3680_0_1, dd_Smed_v6_3680_0_1, [Score=220, Expect=5e-69]} {RNA1509_52690} {RNA1310_22590.1} {RNA815_11166}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA